About

Professor Mohammad Nutan is associated with the Texas A&M Irma Lerma Rangel College of Pharmacy. The provided page text does not include specific details about his research focus, background, or key contributions. Therefore, a detailed professional biography cannot be extracted from the given information.

Research topics

• Organic chemistry
• Chemistry
• Nuclear chemistry

Selected publications

• Drug and formulation development processes

  Elsevier eBooks · 2024-01-01 · 2 citations

  book-chapter
  PublisherDOI

• Oral Bioavailability Enhancement of Poorly Soluble Drug by Amorphous Solid Dispersion Using Sucrose Acetate Isobutyrate

  AAPS PharmSciTech · 2024-09-05 · 1 citations

  article
  PublisherDOI

• Current update and challenges of implementing 3D printing technologies in pharmaceutical manufacturing

  Elsevier eBooks · 2024-01-01 · 1 citations

  book-chapter
  PublisherDOI

• Development and Validation of Matrix of Chemistry, Manufacturing, and Control (MoCMC) System for Intramammary Drug Products (IMM)

  Pharmaceutical Research · 2024-04-01 · 4 citations

  article
  PublisherDOI

• Application of Sucrose Acetate Isobutyrate in Development of Co-Amorphous Formulations of Tacrolimus for Bioavailability Enhancement

  Pharmaceutics · 2023-05-09 · 6 citations

  articleOpen access

  The focus of the present work was to develop co-amorphous dispersion (CAD) formulations of tacrolimus (TAC) using sucrose acetate isobutyrate as a carrier, evaluate by in vitro and in vivo methods and compare its performance with hydroxypropyl methylcellulose (HPMC) based amorphous solid dispersion (ASD) formulation. CAD and ASD formulations were prepared by solvent evaporation method followed by characterization by Fourier transformed infrared spectroscopy, X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), dissolution, stability, and pharmacokinetics. XRPD and DSC indicated amorphous phase transformation of the drug in the CAD and ASD formulations, and dissolved more than 85% of the drug in 90 min. No drug crystallization was observed in the thermogram and diffractogram of the formulations after storage at 25 °C/60% RH and 40 °C/75% RH. No significant change in the dissolution profile was observed after and before storage. SAIB-based CAD and HPMC-based ASD formulations were bioequivalent as they met 90% confidence of 90–11.1% for Cmax and AUC. The CAD and ASD formulations exhibited Cmax and AUC 1.7–1.8 and 1.5–1.8 folds of tablet formulations containing the drug’s crystalline phase. In conclusion, the stability, dissolution, and pharmacokinetic performance of SAIB-based CAD and HPMC-based ASD formulations were similar, and thus clinical performance would be similar.

  PublisherOA PDFDOI

• Compounding Education in US PharmD Curricula

  American Journal of Pharmaceutical Education · 2023-05-24 · 7 citations

  articleOpen accessCorresponding

  OBJECTIVE: To determine the extent of compounding education (CE) offered in United States (US) doctor of pharmacy curricula. METHODS: A 24-item survey instrument addressing various aspects of CE was developed and validated. An email containing the link to the survey instrument was shared with instructors of compounding at 122 of 141 accredited schools and colleges of pharmacy in the US. RESULTS: Of these, 112 schools and colleges responded, rendering a survey response rate of 91.8%. Survey results indicate that CE is offered to a similar extent either as a required standalone course or as integrated instruction as part of a standard course. Whereas 70.8% of programs reported mostly hands-on training in CE in their curricula, there were about 11% programs that mostly offered didactic instruction in CE. Dispersed systems and semisolid formulations are the most prepared in nonsterile compounding, while proper hand washing, garbing, and gloving are the most taught techniques in sterile compounding. Compounding education is delivered principally by pharmaceutics faculty (62.3%) compared to practice faculty (32.1%). CONCLUSION: The survey determined the extent to which CE is addressed across different schools and colleges of pharmacy in the US. Although some institutions lack minimal nonsterile or sterile compounding facilities, they may improve by modeling the established programs in the country. Leadership at pharmacy institutions may need to allocate funds for CE, and support faculty who instruct in compounding.

  PublisherOA PDFDOI

• Contributors

  Elsevier eBooks · 2023-01-01

  book-chapter
  PublisherDOI

• Development and Validation of Discriminatory In-vitro Release Method for Intramammary Drug Product

  Pharmaceutical Research · 2023-10-02 · 5 citations

  articleSenior authorCorresponding
  PublisherDOI

• Quality Control and Regulatory Landscape of 3D-Printed Drug Products

  AAPS advances in the pharmaceutical sciences series · 2023-12-01 · 4 citations

  book-chapter
  PublisherDOI

• In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery

  Journal of Pharmaceutical Sciences · 2022-03-14 · 5 citations

  article
  PublisherDOI

Frequent coauthors

• Mansoor A. Khan

  Hayatabad Medical Complex

  65 shared

• Ziyaur Rahman

  Texas A&M Health Science Center

  44 shared

• Eman M. Mohamed

  Texas A&M Health Science Center

  37 shared

• Sathish Dharani

  Texas A&M Health Science Center

  24 shared

• Tahir Khuroo

  Texas A&M Health Science Center

  12 shared

• Indra K. Reddy

  11 shared

• Canberk Kayalar

  Texas A&M Health Science Center

  10 shared

• Rakhi B. Shah

  9 shared

Labs

• Pharmaceutical SciencesPI

Awards & honors

• Presidential Impact Fellow